Literature DB >> 28484840

Epidemiology of ventricular tachyarrhythmia : Any changes in the past decades?

Benjamin Jong-Ming Pang1, Martin Stephen Green2.   

Abstract

Ventricular tachyarrhythmias include potentially lethal episodes of sustained ventricular tachycardia (VT) and ventricular fibrillation (VF) as well as hemodynamically tolerated ventricular ectopic activity. Sustained VT or VF may develop in the setting of acute myocardial infarction or as clinical sequelae of advanced cardiomyopathy. The incidence of these serious arrhythmias is estimated from retrospective and observational studies and registries of sudden cardiac arrest and sudden cardiac death. Over the past few decades, there has been a gradual decline in the incidence of life-threatening ventricular tachyarrhythmias which has been largely driven by upstream treatments for and prevention of coronary artery disease and its sequelae. In addition primary prevention implantable cardioverter-defibrillators (ICDs) have improved survival in patients at risk for malignant ventricular arrhythmias and sudden cardiac death. Improved understanding, and improved diagnostic and imaging methods have elucidated many of the previously classified "idiopathic" ventricular arrhythmias as inherited arrhythmic syndromes and occult cardiomyopathies. In addition, improved sensitivity and duration of ECG monitoring has allowed increased detection of ventricular ectopic activity.

Entities:  

Keywords:  Implantable cardioverter-defibrillators; Sudden cardiac arrest; Sudden cardiac death; Ventricular ectopic activity; Ventricular fibrillation

Mesh:

Year:  2017        PMID: 28484840     DOI: 10.1007/s00399-017-0503-5

Source DB:  PubMed          Journal:  Herzschrittmacherther Elektrophysiol        ISSN: 0938-7412


  72 in total

Review 1.  Pulseless electric activity: definition, causes, mechanisms, management, and research priorities for the next decade: report from a National Heart, Lung, and Blood Institute workshop.

Authors:  Robert J Myerburg; Henry Halperin; Debra A Egan; Robin Boineau; Sumeet S Chugh; Anne M Gillis; Joshua I Goldhaber; David A Lathrop; Peter Liu; James T Niemann; Joseph P Ornato; George Sopko; Jennifer E Van Eyk; Gregory P Walcott; Myron L Weisfeldt; Jacqueline D Wright; Douglas P Zipes
Journal:  Circulation       Date:  2013-12-03       Impact factor: 29.690

2.  Epidemiology of dilated cardiomyopathy. A prospective post-mortem study of 5252 necropsies. The Heart Muscle Disease Study Group.

Authors:  S Rakar; G Sinagra; A Di Lenarda; A Poletti; R Bussani; F Silvestri; F Camerini
Journal:  Eur Heart J       Date:  1997-01       Impact factor: 29.983

3.  Executive summary: heart disease and stroke statistics--2010 update: a report from the American Heart Association.

Authors:  Donald Lloyd-Jones; Robert J Adams; Todd M Brown; Mercedes Carnethon; Shifan Dai; Giovanni De Simone; T Bruce Ferguson; Earl Ford; Karen Furie; Cathleen Gillespie; Alan Go; Kurt Greenlund; Nancy Haase; Susan Hailpern; P Michael Ho; Virginia Howard; Brett Kissela; Steven Kittner; Daniel Lackland; Lynda Lisabeth; Ariane Marelli; Mary M McDermott; James Meigs; Dariush Mozaffarian; Michael Mussolino; Graham Nichol; Véronique L Roger; Wayne Rosamond; Ralph Sacco; Paul Sorlie; Randall Stafford; Thomas Thom; Sylvia Wasserthiel-Smoller; Nathan D Wong; Judith Wylie-Rosett
Journal:  Circulation       Date:  2010-02-23       Impact factor: 29.690

4.  Relationship of premature systoles to coronary heart disease and sudden death in the Tecumseh epidemiologic study.

Authors:  B N Chiang; L V Perlman; L D Ostrander; F H Epstein
Journal:  Ann Intern Med       Date:  1969-06       Impact factor: 25.391

5.  Ventricular tachycardia in cardiac sarcoidosis: characterization of ventricular substrate and outcomes of catheter ablation.

Authors:  Saurabh Kumar; Chirag Barbhaiya; Koichi Nagashima; Eue-Keun Choi; Laurence M Epstein; Roy M John; Melanie Maytin; Christine M Albert; Amy L Miller; Bruce A Koplan; Gregory F Michaud; Usha B Tedrow; William G Stevenson
Journal:  Circ Arrhythm Electrophysiol       Date:  2014-12-19

6.  Trends in treated ventricular fibrillation out-of-hospital cardiac arrest: a 17-year population-based study.

Authors:  T Jared Bunch; Roger D White; Paul A Friedman; Thomas E Kottke; Lambert A Wu; Douglas L Packer
Journal:  Heart Rhythm       Date:  2004-09       Impact factor: 6.343

7.  The relationships among ventricular arrhythmias, left ventricular dysfunction, and mortality in the 2 years after myocardial infarction.

Authors:  J T Bigger; J L Fleiss; R Kleiger; J P Miller; L M Rolnitzky
Journal:  Circulation       Date:  1984-02       Impact factor: 29.690

8.  Implantable cardioverter-defibrillators have reduced the incidence of resuscitation for out-of-hospital cardiac arrest caused by lethal arrhythmias.

Authors:  Michiel Hulleman; Jocelyn Berdowski; Joris R de Groot; Pascal F H M van Dessel; C Jan Willem Borleffs; Marieke T Blom; Abdenasser Bardai; Carel C de Cock; Hanno L Tan; Jan G P Tijssen; Rudolph W Koster
Journal:  Circulation       Date:  2012-08-06       Impact factor: 29.690

9.  Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy.

Authors:  Alan Kadish; Alan Dyer; James P Daubert; Rebecca Quigg; N A Mark Estes; Kelley P Anderson; Hugh Calkins; David Hoch; Jeffrey Goldberger; Alaa Shalaby; William E Sanders; Andi Schaechter; Joseph H Levine
Journal:  N Engl J Med       Date:  2004-05-20       Impact factor: 91.245

10.  Current burden of sudden cardiac death: multiple source surveillance versus retrospective death certificate-based review in a large U.S. community.

Authors:  Sumeet S Chugh; Jonathan Jui; Karen Gunson; Eric C Stecker; Benjamin T John; Barbara Thompson; Nasreen Ilias; Catherine Vickers; Vivek Dogra; Mohamud Daya; Jack Kron; Zhi-Jie Zheng; George Mensah; John McAnulty
Journal:  J Am Coll Cardiol       Date:  2004-09-15       Impact factor: 24.094

View more
  1 in total

1.  A new perspective for phase analysis of radionuclide angiocardiography.

Authors:  Claudine Régis; François Rouzet
Journal:  J Nucl Cardiol       Date:  2022-02-08       Impact factor: 5.952

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.